glp-1 drugs stocks Best Weight Loss Drug to Buy in 2026 Weekend thoughts: GLP-1 drugs and
Description
Initial investigations into the cardiovascular safety effects of glucose-lowering medications in patients with T2D revealed an unexpected reduction in CV complications and mortality with the use glucagon-like peptide 1 receptor agonists (GLP1-RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2is)
Medicare Part D can cover Ozempic or Mounjaro for Type 2 diabetes but cannot cover Wegovy or Zepbound for weight loss
"GLP-1 receptor agonists do more than regulate blood sugar - they also protect the heart
Lancet (London England)
FDAs Concers With Unapproved GLLP-1 Drugs Used for Weight Loss
In between, we can have an RN do a check to see how things are coming, make sure everythings okay
